Treatment failure of pyrimethamine-sulphadoxine and induction of Plasmodium falciparum gametocytaemia in children in western Kenya

Tropical Medicine and International Health

Volumn 8, Issue 5, 2003, Pages 427-430

  Bousema, J T ^a   Gouagna, L C ^b   Meutstege, A M ^a,e   Okech, B E ^b,c   Akim, N I J ^b   Githure, J I ^b   Beier, J C ^d   Sauerwein, R W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INTERNATIONAL CENTRE OF INSECT PHYSIOLOGY AND ECOLOGY ICIPE   (Kenya)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Gametocyte; Kenya; Malaria; Plasmodium falciparum; Pyrimethamine; Resistance; Sulfadoxine

Indexed keywords

ANTIMALARIAL AGENT; FANSIDAR; PYRIMETHAMINE; SULFADOXINE;

CHILD HEALTH; MALARIA; PERFORMANCE ASSESSMENT; PEST RESISTANCE;

ADOLESCENT; ARTICLE; CHILD; FEMALE; GAMETOCYTE; HUMAN; INFANT; KENYA; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MALE; MULTIDRUG RESISTANCE; PLASMODIUM FALCIPARUM; POPULATION DENSITY; PREVALENCE; TREATMENT FAILURE; TROPHOZOITE;

ADOLESCENT; ANIMALS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KENYA; MALARIA, FALCIPARUM; MALE; PARASITEMIA; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; RURAL HEALTH; SULFADOXINE; TREATMENT FAILURE;

KENYA;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0037666198     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2003.01047.x     Document Type: Article

References (17)

1. Akim NI, Drakeley C, Kingo T, Simon B, Senkoro K & Sauerwein RW (2000) Dynamics of P. falciparum gametocytemia in symptomatic patients in an area of intense perennial transmission in Tanzania. American Journal of Tropical Medicine and Hygiene 63, 199-203.
2. Hogh B, Gamage-Mendis A, Butcher GA et al. (1998) The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector. American Journal of Tropical Medicine and Hygiene 58, 176-182.
3. Hogh B, Thompson R, Hetzel C et al. (1995) Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of Mozambique. American Journal of Tropical Medicine and Hygiene 52, 50-59.
4. Nevill CG, Ochen K, Munafu CG, Bekobita D & Sezi CL (1995) Response of Plasmodium falciparum to chloroquine and Fansidar in vivo and chloroquine and amodiaquine in vitro in Uganda. East African Medical Journal 72, 349-354.
5. Ogutu BR, Smoak BL, Nduati RW, Mbori-Ngacha DA, Mwathe F & Shanks GD (2000) The efficacy of pyrimethamine-sulfadoxine (Fansidar®) in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 83-84.
6. Price RN, Nosten F, Luxemburger C et al. (1996) Effects of artemisinin derivatives on malaria transmissibility. Lancet 347, 1654-1658.
7. Price RN, Nosten F, Simpson JA et al. (1999) Risk factors for gametocyte carriage in uncomplicated falciparum malaria. American Journal of Tropical Medicine Hygiene 60, 1019-1023.
8. Robert V, Awono-Ambene HP, Le Hesran JY & Trape JF (2000) Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine. American Journal of Tropical Medicine Hygiene 62, 210-216.
9. Ronn AM, Msangeni HA, Mhina J, Wernsdorfer WH & Bygbjerg IC (1996) High level of resistance of P. falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene 90, 179-181.
10. Shute GT (1988) The microscopic diagnosis of malaria.In: Malaria, Principles and Practice of Malariology (eds WH Wensdorfer & I McGregor). Churchill Livingstone, Edinburgh, pp. 781-814.
11. Sokhna CS, Trape JF, Robert V (2001) Gametocytaemia in Senegalese children with uncomplicated falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine-pyrimethamine. Parasite 8, 243-250.
12. Targett G, Drakeley C, Jawara M et al. (2001) Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. Journal of Infectious Diseases 183, 1254-1259.
13. Tjitra E, Suprianto S & Anstey NM (2002) Higher gametocyte prevalence following failure of treatment of Plasmodium falciparum malaria with sulfadoxine-pyrimethamine and the combination of chloroquine plus sulfadoxine-pyrimethamine: implications for progression of anti-folate resistance. Transactions of the Royal Society of Tropical Medicine and Hygiene 96, 434-437.
14. Van Dillen J, Custers M, Wensink A et al. (1999) A comparison of amodiaquine and sulfadoxine-pyrimethamine as first-line treatment of falciparum malaria in Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 185-188.
15. Von Seidlein L, Jawara M, Coleman R, Doherty T, Walraven G & Targett G (2001) Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria. Tropical Medicine and International Health 6, 92-98.
16. Watkins WM & Mosobo M (1993) Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Transactions of the Royal Society of Tropical Medicine and Hygiene 87, 75-78.
17. White NJ, Nosten F, Looareesuwan S et al. (1999) Averting a malaria disaster. Lancet 353, 1965-1967.